Back to GetFilings.com



 



SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

For Quarter Ended March 31, 2003

Commission File Number 1-5620

SAFEGUARD SCIENTIFICS, INC.

(Exact name of registrant as specified in its charter)
     
Pennsylvania   23-1609753
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification Number)
     
800 The Safeguard Building,    
435 Devon Park Drive Wayne, PA   19087
(Address of principal executive offices)   (Zip Code)

(610) 293-0600
Registrant’s telephone number, including area code

     Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes   þ   No   o

     Indicate by check mark whether the Registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2).

Yes   þ   No   o

Number of shares outstanding as of April 25, 2003
Common Stock 119,310,523



 


 

SAFEGUARD SCIENTIFICS, INC.
QUARTERLY REPORT FORM 10-Q
INDEX

           
      Page
     
PART I - FINANCIAL INFORMATION
       
Item 1 - Financial Statements:
       
 
Consolidated Balance Sheets - March 31, 2003 (unaudited) and December 31, 2002
    3  
 
Consolidated Statements of Operations (unaudited) - Three Months Ended March 31, 2003 and 2002
    4  
 
Consolidated Statements of Cash Flows (unaudited) - Three Months Ended March 31, 2003 and 2002
    5  
 
Notes to Consolidated Financial Statements
    6  
Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations
    26  
Item 3 - Quantitative and Qualitative Disclosures About Market Risk
    35  
Item 4 – Controls and Procedures
    35  
PART II - OTHER INFORMATION
       
Item 1 - Legal Proceedings
    36  
Item 6 - Exhibits and Reports on Form 8-K
    36  
Signatures
    37  
Certifications
    38  

2


 

SAFEGUARD SCIENTIFICS, INC.

CONSOLIDATED BALANCE SHEETS

                         
            March 31,   December 31,
            2003   2002
           
 
            (in thousands except per share data)
            (unaudited)        
       
ASSETS
               
Current Assets
               
 
Cash and cash equivalents
  $ 250,949     $ 254,779  
 
Restricted cash
    1,632       3,634  
 
Short-term investments
    7,984       9,986  
 
Trading securities
    768       832  
 
Accounts receivable, less allowances ($3,637 - 2003; $3,523 - 2002)
    125,526       179,668  
 
Inventories
    26,327       30,181  
 
Prepaid expenses and other current assets
    14,610       13,045  
 
 
   
     
 
   
Total current assets
    427,796       492,125  
Property and equipment, net
    38,140       38,610  
Ownership interests in and advances to affiliates
    77,691       74,859  
Available-for-sale securities
    4,474       4,548  
Intangible assets, net
    17,209       18,580  
Goodwill, net
    206,513       206,815  
Deferred taxes
    847       1,210  
Note receivable - related party
    13,751       14,482  
Other
    15,365       17,437  
 
 
   
     
 
   
Total Assets
  $ 801,786     $ 868,666  
 
 
   
     
 
     
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Current Liabilities
               
 
Current maturities of long-term debt
  $ 12,043     $ 11,517  
 
Accounts payable
    90,598       121,793  
 
Accrued expenses and deferred revenue
    94,372       116,669  
 
 
   
     
 
   
Total current liabilities
    197,013       249,979  
Long-term debt
    2,221       1,998  
Minority interest
    129,620       130,384  
Other long-term liabilities
    15,550       14,032  
Convertible subordinated notes
    200,000       200,000  
Commitments and contingencies
               
Shareholders’ Equity
               
 
Preferred stock, $10.00 par value; 1,000 shares authorized
           
 
Common stock, $0.10 par value; 500,000 shares authorized; 119,450 shares issued and outstanding in 2003 and 2002
    11,945       11,945  
 
Additional paid-in capital
    738,282       738,282  
 
Accumulated deficit
    (492,406 )     (476,867 )
 
Accumulated other comprehensive income
    2,474       2,522  
 
Treasury stock, at cost (136 shares-2003; 33 shares-2002)
    (396 )     (129 )
 
Unamortized deferred compensation
    (2,517 )     (3,480 )
 
 
   
     
 
   
Total shareholders’ equity
    257,382       272,273  
 
 
   
     
 
   
Total Liabilities and Shareholders’ Equity
  $ 801,786     $ 868,666  
 
 
   
     
 

See Notes to Consolidated Financial Statements.

3


 

SAFEGUARD SCIENTIFICS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

                     
        Three Months Ended March 31,
       
        2003   2002
       
 
        (in thousands, except per share data)
        (unaudited)
Revenue
               
 
Product sales
  $ 260,311     $ 262,767  
 
Service sales
    109,489       82,463  
 
Other
    899       5,574  
 
 
   
     
 
   
Total revenue
    370,699       350,804  
 
 
   
     
 
Operating Expenses
               
 
Cost of sales-product
    235,906       233,258  
 
Cost of sales-service
    72,549       54,920  
 
Selling and service
    34,875       29,487  
 
General and administrative
    30,724       34,634  
 
Depreciation and amortization
    7,878       7,401  
 
 
   
     
 
   
Total operating expenses
    381,932       359,700  
 
 
   
     
 
 
    (11,233 )     (8,896 )
Other income (loss), net
    4,191       (5,531 )
Impairment – related party (Note 15)
    (659 )      
Interest income
    1,032       2,020  
Interest and financing expense
    (3,444 )     (7,465 )
 
 
   
     
 
Loss before income taxes, minority interest, equity loss and change in accounting principle
    (10,113 )     (19,872 )
Income taxes
    (1,392 )     (1,118 )
Minority interest
    (10 )     (841 )
Equity loss
    (4,024 )     (18,907 )
 
 
   
     
 
Net loss before change in accounting principle
    (15,539 )     (40,738 )
Cumulative effect of change in accounting principle (Note 3)
          (21,390 )
 
 
   
     
 
Net Loss
  $ (15,539 )   $ (62,128 )
 
 
   
     
 
Basic Loss Per Share:
               
 
Prior to cumulative effect of change in accounting principle
  $ (0.13 )   $ (0.35 )
 
Cumulative effect of change in accounting principle
          (0.18 )
 
 
   
     
 
 
  $ (0.13 )   $ (0.53 )
 
 
   
     
 
Diluted Loss Per Share:
               
 
Prior to cumulative effect of change in accounting principle
  $ (0.14 )   $ (0.35 )
 
Cumulative effect of change in accounting principle
          (0.18 )
 
 
   
     
 
 
  $ (0.14 )   $ (0.53 )
 
 
   
     
 
Weighted Average Shares Outstanding - Basic and Diluted
    118,163       117,523  

See Notes to Consolidated Financial Statements.

4


 

SAFEGUARD SCIENTIFICS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

                   
      Three Months Ended March 31,
     
      2003   2002
     
 
      (in thousands)
      (unaudited)
Net cash used in operating activities
  $ (4,861 )   $ (28,284 )
Investing Activities
               
Proceeds from sales of available-for-sale and trading securities
    49       13,167  
Proceeds from sales of and distributions from affiliates
    5,252       9,211  
Advances to affiliates
          (2,241 )
Repayment of advances to affiliates
    753        
Acquisitions of ownership interests in affiliates and subsidiaries, net of cash acquired
    (5,670 )     (5,096 )
Repayments of advances to related party
    72       1,372  
Increase in restricted cash and short-term investments
          (1,609 )
Decrease in restricted cash and short-term investments
    4,004        
Capital expenditures
    (3,888 )     (2,143 )
Other, net
    (341 )     (535 )
 
   
     
 
 
Net cash provided by investing activities
    231       12,126  
Financing Activities
               
Borrowings on revolving credit facilities
    1,346       6,629  
Repayments on revolving credit facilities
          (7,151 )
Borrowings on long-term debt
    80       569  
Repayments on long-term debt
    (698 )     (786 )
Issuance of subsidiary common stock
    72       420  
 
   
     
 
 
Net cash provided by (used in) financing activities
    800       (319 )
Net Decrease in Cash and Cash Equivalents
    (3,830 )     (16,477 )
Cash and Cash Equivalents at beginning of period
    254,779       298,095  
 
   
     
 
Cash and Cash Equivalents at end of period
  $ 250,949     $ 281,618  
 
   
     
 

See Notes to Consolidated Financial Statements.

5


 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2003

1.     GENERAL

     The accompanying unaudited interim Consolidated Financial Statements were prepared in accordance with accounting principles generally accepted in the United States of America and the interim financial statements rules and regulations of the SEC. In the opinion of management, these statements include all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of the Consolidated Financial Statements. The interim operating results are not necessarily indicative of the results for a full year or for any interim period. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations relating to interim financial statements. The Consolidated Financial Statements included in this Form 10-Q should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations and the Company’s Consolidated Financial Statements and Notes thereto included in the Company’s 2002 Annual Report on Form 10-K.

2.     BASIS OF PRESENTATION

     The Consolidated Financial Statements include the accounts of the Company and all subsidiaries in which it directly or indirectly owns more than 50% of the outstanding voting securities. The Company’s wholly-owned subsidiaries include Alliance Consulting Group Associates, Inc. (“Alliance Consulting”). The Company’s Consolidated Statements of Operations and Cash Flows also include the following majority-owned subsidiaries:

     
For the three months ended March 31,

2003   2002

 
Agari Mediaware   Agari Mediaware
ChromaVision Medical Systems   Aptas (through March 2002)
CompuCom Systems   CompuCom Systems
Mantas   Pacific Title and Arts Studio
Pacific Title and Arts Studio   Protura Wireless (since January 2002)
Protura Wireless   SOTAS
SOTAS   Tangram Enterprise Solutions
Tangram Enterprise Solutions    

     The Company’s Consolidated Balance Sheets also include the following majority-owned subsidiaries at both March 31, 2003 and December 31, 2002:

 
Agari Mediaware
ChromaVision Medical Systems
CompuCom Systems
Mantas
Pacific Title and Arts Studio
Protura Wireless
SOTAS
Tangram Enterprise Solutions

6


 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
MARCH 31, 2003

3.     RECLASSIFICATIONS

     Certain prior year amounts have been reclassified to conform to the current year presentation.

     The Company adopted SFAS 142, “Goodwill and Other Intangible Assets” during the three months ended June 30, 2002, effective January 1, 2002. In accordance with the provision of SFAS 142, the Company recorded a cumulative effect of a change in accounting principle in the Consolidated Statements of Operations, resulting in an increase in the Company’s net loss by $21.8 million for the three months ended March 31, 2002.

4.     GOODWILL AND OTHER INTANGIBLE ASSETS

     Under the transition provisions of SFAS 142, the Company was required to test existing goodwill and intangible assets with indefinite useful lives for impairment as of January 1, 2002. The Company completed the required testing during the second quarter of 2002. As a result, the Company reported a $21.8 million goodwill impairment loss in the Business and IT services reporting unit (a component of the Strategic Initiative segment), arising from the initial application of SFAS 142 which required the carrying amount of goodwill be compared to the fair value. The fair value of that reporting unit was determined by estimating the present value of future cash flows and by reviewing the valuations of comparable public companies.

     Goodwill balances are consistent with the December 31, 2002 balances. There is an immaterial purchase price adjustment related to the recent acquisition of Alliance Consulting, which is included in the strategic initiative segment (Note 14).

     The following is a summary of changes in the carrying amount of goodwill by segment:

                                 
    Strategic                        
    Initiative   Legacy           Total
    Companies   Companies   CompuCom   Segments
   
 
 
 
    (in thousands)
    (unaudited)
Balance at December 31, 2002
  $ 91,337     $ 10,589     $ 104,889     $ 206,815  
Acquisitions
    (302 )                 (302 )
 
   
     
     
     
 
Balance at March 31, 2003
  $ 91,035     $ 10,589     $ 104,889     $ 206,513  
 
   
     
     
     
 

     Intangible assets with definite useful lives are amortized over their respective estimated useful lives to their estimated residual values. The following table provides a summary of the Company’s intangible assets with definite useful lives:

                                 
    March 31, 2003
   
            Gross                
    Amortization   Carrying   Accumulated        
    Period   Value   Amortization   Net
   
 
 
 
                    (in thousands)        
                    (unaudited)        
Customer-related
  6 - 11 years   $ 15,467     $ 9,700     $ 5,767  
Contract-related
  2 - 3 years     2,840       1,601       1,239  
Technology-related
  2 - 17 years     14,307       4,104       10,203  
 
           
     
     
 
Total
          $ 32,614     $ 15,405     $ 17,209  
 
           
     
     
 

7


 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
MARCH 31, 2003

                                 
    December 31, 2002
   
            Gross                
    Amortization   Carrying   Accumulated        
    Period   Value   Amortization   Net
   
 
 
 
            (in thousands)
Customer-related
  6 - 11 years   $ 15,467     $ 9,107     $ 6,360  
Contract-related
  2 - 3 years     2,840       1,382       1,458  
Technology-related
  2 - 17 years     14,071       3,309       10,762  
 
           
     
     
 
Total
          $ 32,378     $ 13,798     $ 18,580  
 
           
     
     
 

     Amortization expense related to intangible assets was $1.6 million and $1.0 million for the three months ended March 31, 2003 and 2002, respectively. The following table provides estimated future amortization expense related to intangible assets:

         
    Total
   
    (in thousands)
    (unaudited)
Remainder of 2003
  $ 4,611  
2004
    5,529  
2005
    3,614  
2006
    1,488  
2007 and thereafter
    1,967  
 
   
 
 
  $ 17,209  
 
   
 

5.     NEW ACCOUNTING PRONOUNCEMENTS

     In August 2001, the FASB issued Statement of Financial Accounting Standards No. 143, “Accounting for Asset Retirement Obligations”. SFAS 143 requires entities to record the fair value of a liability for an asset retirement obligation in the period in which it is incurred. The Company has adopted SFAS 143 as of January 1, 2003. The adoption did not have any significant impact on its financial statements.

     In July 2002, the FASB Issued SFAS No. 146, “Accounting for Costs Associated with Exit or Disposal Activities,” which addresses the financial accounting and reporting of expenses related to restructurings initiated after 2002, and applies to costs associated with an exit activity (including a restructuring) or with a disposal of long-lived assets. Those activities can include eliminating or reducing product lines, terminating employees and contracts, and relocating plant facilities or personnel. Under SFAS No.146, a company will record a liability for a cost associated with an exit or disposal activity when the liability is incurred and can be measured at fair value. The provisions of SFAS No. 146 are effective prospectively for exit or disposal activities initiated after December 31, 2002. The adoption of this statement had no effect on the Company’s financial statements.

     In November 2002, the FASB issued FASB Interpretation No. 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others, an Interpretation of FASB Statements No. 5, 57, and 107 and rescission of FASB Interpretation No. 34”. The Interpretation expands on the disclosure requirements to be made in interim and annual financial statements. The disclosure requirements are effective for financial statements of both interim and annual periods that end after December 15, 2002. The Interpretation also requires that a liability measured at fair value be recognized for guarantees even if the probability of payment on the guarantee is remote. The provision for initial recognition and measurement should be applied on a prospective basis to guarantees issued or modified after December 31, 2002. The Company adopted the provisions of FASB Interpretation No. 45 as of January 1, 2003. The adoption did not have a material impact on the Company’s financial statements.

8


 

SAFEGUARD SCIENTIFICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
MARCH 31, 2003

     In November 2002, the Emerging Issues Task Force (EITF) reached a consensus on Issue No. 00-21, “Accounting for Revenue Arrangements with Multiple Deliverables.” This issue addresses the appropriate accounting by vendors for arrangements that will result in the delivery of multiple products, services and/or rights to assets that may occur over a period of time. The Issue is effective for revenue arrangements entered into in fiscal periods beginning after June 15, 2003. The Company is currently evaluating the impact of the adoption of this consensus on the Company’s consolidated financial statements.

     In January 2003, the FASB issued Interpretation No. 46, which addresses the consolidation by business enterprises of variable interest entities as defined in the Interpretation. The Interpretation applies immediately to variable